RESEARCH POSTER PRESENTATION DESIGN © 2015
www.PosterPresentations.com
1. ClinicalTrials.gov. Neuro RX Gamma - Pivotal Phase. Accessed July 2019:https://clinicaltrials.gov/ct2/show/NCT03484143.2. Iaccarino HF, Singer AC, Martorell AJ et al. Gamma frequency entrainmentattenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230-235.3. Perea JR, Llorens-Martín M, Ávila J, et al. The Role of Microglia in the Spreadof Tau: Relevance for Tauopathies. Front Cell Neurosci. 2018; 12: 172.4. Albrecht-Buehler G. Cellular infrared detector appears to be contained in thecentrosome. Cell Motil Cytoskeleton. 1994;27(3):262-71.5. Hamblin, M.R. Photobiomodulation for Alzheimer’s Disease: Has the LightDawned? Photonics 2019; 6:77.6. Cooper CE, Cope M, Springett R, et al. D.T. Use of Mitochondrial Inhibitors toDemonstrate That Cytochrome Oxidase Near-Infrared Spectroscopy Can MeasureMitochondrial Dysfunction Noninvasively in the Brain. Br. J. Pharmacol. 1999;19:27–38.7. Karu TI. Multiple roles of cytochrome c oxidase in mammalian cells underaction of red and IR-A radiation. IUBMB Life. 2010; 62:607–610.8. Sommer AP. Mitochondrial cytochrome c oxidase is not the primary acceptor fornear infrared light—It is mitochondrial bound water: The principles of low-levellight therapy. Ann. Transl. Med. 2019 7:S13.9. Lee HI, Lee SW, Kim SY, et al. Pretreatment with light-emitting diode therapyreduces ischemic brain injury in mice through endothelial nitric oxide synthase-dependent mechanisms. Biochem. Biophys. Res. Commun. 2017; 486:945–950.10. Lim W, Kim J, Kim S, et al. Modulation of lipopolysaccharide-induced NF-kappaB signaling pathway by 635 nm irradiation via heat shock protein 27 inhuman gingival fibroblast cells. Photochem. Photobiol. 2013; 89:199–207.11. Yamaura M, Yao M, Yaroslavsky I, et al. Low level light effects oninflammatory cytokine production by rheumatoid arthritis synoviocytes. LasersSurg. Med. 2009; 41:282–290.12. Xuan W, Vatansever F, Huang L., et al. Transcranial low-level laser therapyenhances learning, memory, and neuroprogenitor cells after traumatic brain injuryin mice. J. Biomed. Opt. 2014; 19:108003.13. Meng C, He Z and Xing D. Low-Level Laser Therapy Rescues DendriteAtrophy via Upregulating BDNF Expression: Implications for Alzheimer’sDisease. J. Neurosci. 2013; 33:13505–13517.14. Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction inAlzheimer disease. Nat Rev Neurosci. 2016; 17(12):777-792.15. Saltmarche AE, Naeser MA, Ho KF, et al Significant Improvement inCognition in Mild to Moderately Severe Dementia Cases Treated with TranscranialPlus Intranasal Photobiomodulation: Case Series Report. Photomed. Laser Surg.2017;35:432–441.16. Chao LL. Effects of Home Photobiomodulation Treatments on Cognitive andBehavioral Function, Cerebral Perfusion, and Resting-State FunctionalConnectivity in Patients with Dementia: A Pilot Trial. Photobiomodul. Photomed.Laser Surg. 2019; 37:133–141.17. Zomorrodi R, Loheswaran G, Pushparaj A & Lim L. Pulsed Near InfraredTranscranial and Intranasal Photobiomodulation Significantly Modulates NeuralOscillations: a pilot exploratory study. Scientific Reports. 2019; 9:6309.
REFERENCES
Lew Lim, PhD, MBA
Vielight Inc, Toronto, ON, Canada
Photobiomodulation Pathway Map in addressing Alzheimer's Disease with Vielight Neuro GammaPresented at: Alzheimer’s Association International Conference, July 14-18, 2019
Key Parameters:
• 810 nm Near Infrared Light
• Pulse rate of 40 Hz
• Targeting the Default Mode Network
• 20 min/day/6-day-week, home-use
• Total energy dose of 240 J
Delta Theta Alpha Beta Gamma
Frequency band
0
2
4
6
8
10
12
Abso
lute
Pow
er s
pect
rum
Active
Sham
Weeks
Chan
ge in
ADA
S-co
g fr
om b
asel
ine
-12
-10
-8
-6
-4
-2
0
2
4
6
8
PBM UC
Single Intervention withVielight Neuro Gamma Cellular-level Effects
Factors affecting Alzheimer’s Disease
Clinical Outcomes as at June 2019
M2 Microglia2,3
Mitochondria5
Interfacial Water Layer8
Β-amyloid oligomers2
Tau – neurofibrillary tangles3
Memory encoding14
Inflammation10
Blood circulation & oxygenation9
Neurogenesis & synaptogenesis12
Saltmarche et al, 201715
• Journalized reports• MMSE• ADAS-cog
Chao, 201916
• ADAS-cog• NPI• fMRI• ASL
Zommorodi, et al, 201917
• EEG, Power spectrum
• Connectivity
Electron Transport Chain6
Heat-gated ion channels5
Positioning on the Default Mode Network Network and interneurons14
Neurons
Stem/progenitor cells12
Microtubules4
Cytochrome C Oxidase6
ATPROScAMPAP15
NO9
COX-2 inhibitor10
Altered NFKB11
BDNF13
References1. ClinicalTrials.gov. Neuro RX Gamma - Pivotal Phase. Accessed July 2019: https://clinicaltrials.gov/ct2/show/NCT03484143. 2. Iaccarino HF, Singer AC, Martorell AJ et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230-235.3 Adaikkan C, Middleton S.J, Marco A, et al. Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection. Neuron 2019; 102:929–943.4. Albrecht-Buehler G. Cellular infrared detector appears to be contained in the centrosome. Cell Motil Cytoskeleton. 1994;27(3):262-71. 5. Hamblin, M.R. Photobiomodulation for Alzheimer’s Disease: Has the Light Dawned? Photonics 2019; 6:77.6. Cooper CE, Cope M, Springett R, et al. Use of Mitochondrial Inhibitors to Demonstrate That Cytochrome Oxidase Near-Infrared Spectroscopy Can Measure Mitochondrial Dysfunction Noninvasively in the Brain. Br. J. Pharmacol. 1999; 19:27–38.7. Karu TI. Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation. IUBMB Life. 2010; 62:607–610.8. Sommer AP. Mitochondrial cytochrome c oxidase is not the primary acceptor for near infrared light—It is mitochondrial bound water: The principles of low-level light therapy. Ann. Transl. Med. 2019 7:S13.9. Lee HI, Lee SW, Kim SY, et al. Pretreatment with light-emitting diode therapy reduces ischemic brain injury in mice through endothelial nitric oxide synthase-dependent mechanisms. Biochem. Biophys. Res. Commun. 2017; 486:945–950.10. Lim W, Kim J, Kim S, et al. Modulation of lipopolysaccharide-induced NF-kappaB signaling pathway by 635 nm irradiation via heat shock protein 27 in human gingival fibroblast cells. Photochem. Photobiol. 2013; 89:199–207.11. Yamaura M, Yao M, Yaroslavsky I, et al. Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes. Lasers Surg. Med. 2009; 41:282–290.12. Xuan W, Vatansever F, Huang L., et al. Transcranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice. J. Biomed. Opt. 2014; 19:108003.13. Meng C, He Z and Xing D. Low-Level Laser Therapy Rescues Dendrite Atrophy via Upregulating BDNF Expression: Implications for Alzheimer’s Disease. J. Neurosci. 2013; 33:13505–13517.14. Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016; 17(12):777-792.15. Saltmarche AE, Naeser MA, Ho KF, et al Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report. Photomed. Laser Surg. 2017;35:432–441.16. Chao LL. Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial. Photobiomodul. Photomed. Laser Surg. 2019; 37:133–141.17. Zomorrodi R, Loheswaran G, Pushparaj A & Lim L. Pulsed Near Infrared Transcranial and Intranasal Photobiomodulation Significantly Modulates Neural Oscillations: a pilot exploratory study. Scientific Reports. 2019; 9:6309.
The synopsis of this poster is available at https://vielight.com/alzheimers-disease-photobiomodulation-aaic-poster/
Contact:Lew Lim: [email protected]